Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -8.02 |
| peg ratio | 0.08 |
| price to book ratio | 10.01 |
| price to sales ratio | 10.65 |
| enterprise value multiple | -8.60 |
| price fair value | 10.01 |
profitability ratios | |
|---|---|
| gross profit margin | 89.43% |
| operating profit margin | -131.16% |
| pretax profit margin | -140.72% |
| net profit margin | -140.97% |
| return on assets | -44.71% |
| return on equity | -119.11% |
| return on capital employed | -68.67% |
liquidity ratio | |
|---|---|
| current ratio | 2.46 |
| quick ratio | 2.38 |
| cash ratio | 0.78 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 348.77 |
| operating cycle | 506.97 |
| days of payables outstanding | 480.92 |
| cash conversion cycle | 26.06 |
| receivables turnover | 2.31 |
| payables turnover | 0.76 |
| inventory turnover | 1.05 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.48 |
| debt equity ratio | 1.33 |
| long term debt to capitalization | 0.40 |
| total debt to capitalization | 0.57 |
| interest coverage | -6.19 |
| cash flow to debt ratio | -0.81 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.35 |
| cash per share | 2.66 |
| operating cash flow per share | -1.35 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -0.81 |
| short term coverage ratios | -1.68 |
| capital expenditure coverage ratio | -1,125.19 |
Frequently Asked Questions
Arcutis Biotherapeutics, Inc. (ARQT) published its most recent earnings results on 06-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)'s trailing twelve months ROE is -119.11%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Arcutis Biotherapeutics, Inc. (ARQT) currently has a ROA of -44.71%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
ARQT reported a profit margin of -140.97% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.46 in the most recent quarter. The quick ratio stood at 2.38, with a Debt/Eq ratio of 1.33.